Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Open Access
- 21 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (2) , 271-278
- https://doi.org/10.1161/01.cir.0000044943.12533.a8
Abstract
Background— Although reduced endothelial nitric oxide (NO) bioavailability has been demonstrated in arteriosclerotic vascular disease, the integrity of this system in sickle cell disease remains un...Keywords
This publication has 46 references indexed in Scilit:
- Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. SHORT REPORTBritish Journal of Haematology, 2000
- Effect of Estrogen on Isoforms of Nitric Oxide Synthase: Possible Mechanism of Anti-Atherosclerotic Effect of EstrogenGerontology, 1997
- Enhanced Levels of Soluble VCAM-1 in Sickle Cell Patients and Their Specific Increment during Vasoocclusive CrisisClinical Immunology and Immunopathology, 1996
- The metabolites of nitric oxide in sickle‐cell diseaseBritish Journal of Haematology, 1995
- Gender Differences in AtherosclerosisJournal of Cardiovascular Pharmacology, 1995
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.Journal of Clinical Investigation, 1995
- Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During AtherogenesisScience, 1991
- Nitrogen Metabolism in Sickle Cell Anemia: Free Amino Acids in Plasma and UrineThe Lancet Healthy Longevity, 1990
- Adhesion receptors of the immune systemNature, 1990
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986